156 related articles for article (PubMed ID: 24348818)
1. Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin.
Tsoukalas N; Tolia M; Lypas G; Panopoulos C; Barbounis V; Koumakis G; Efremidis A
Oncol Lett; 2014 Jan; 7(1):47-49. PubMed ID: 24348818
[TBL] [Abstract][Full Text] [Related]
2. Complete response of a recurrent-metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature.
Kus T; Aktas G; Kalender ME; Tutar E; Ulker E; Camci C
J Cancer Res Ther; 2015; 11(4):974-6. PubMed ID: 26881560
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.
Grosso F; Jones RL; Demetri GD; Judson IR; Blay JY; Le Cesne A; Sanfilippo R; Casieri P; Collini P; Dileo P; Spreafico C; Stacchiotti S; Tamborini E; Tercero JC; Jimeno J; D'Incalci M; Gronchi A; Fletcher JA; Pilotti S; Casali PG
Lancet Oncol; 2007 Jul; 8(7):595-602. PubMed ID: 17586092
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Demetri GD; Chawla SP; von Mehren M; Ritch P; Baker LH; Blay JY; Hande KR; Keohan ML; Samuels BL; Schuetze S; Lebedinsky C; Elsayed YA; Izquierdo MA; Gómez J; Park YC; Le Cesne A
J Clin Oncol; 2009 Sep; 27(25):4188-96. PubMed ID: 19652065
[TBL] [Abstract][Full Text] [Related]
5. Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report.
Matsuda S; Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
Medicine (Baltimore); 2020 Jan; 99(2):e18689. PubMed ID: 31914068
[TBL] [Abstract][Full Text] [Related]
6. Tumor calcification: a new response pattern of myxoid liposarcoma to trabectedin.
Turpin A; Taieb S; Penel N
Case Rep Oncol; 2014 Jan; 7(1):204-9. PubMed ID: 24803896
[TBL] [Abstract][Full Text] [Related]
7. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.
Wang WL; Katz D; Araujo DM; Ravi V; Ludwig JA; Trent JC; Patel SR; Lin PP; Guadagnolo A; Lòpez-Terrada D; Dei Tos AP; Lewis VO; Lev D; Pollock RE; Zagars GK; Benjamin RS; Madewell JE; Lazar AJ
Clin Sarcoma Res; 2012 Dec; 2(1):25. PubMed ID: 23272660
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of trabectedin for the treatment of liposarcoma.
Zijoo R; von Mehren M
Expert Opin Pharmacother; 2016 Oct; 17(14):1953-62. PubMed ID: 27615729
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
[TBL] [Abstract][Full Text] [Related]
10. An extremely rare case of recurrent pleomorphic myxoidliposarcoma with response to eribulin chemotherapy - A case report.
Rao R; Rastogi S; Kashyap D; Shamim SA; Barwad A
Rare Tumors; 2023; 15():20363613231212380. PubMed ID: 38074447
[TBL] [Abstract][Full Text] [Related]
11. Giant mesenteric myxoid liposarcoma: Challenges of diagnosis and treatment.
Mokfi R; Boutaggount F; Maskrout M; Rais G
Radiol Case Rep; 2022 Nov; 17(11):4227-4231. PubMed ID: 36120521
[TBL] [Abstract][Full Text] [Related]
12. Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Patel S; von Mehren M; Reed DR; Kaiser P; Charlson J; Ryan CW; Rushing D; Livingston M; Singh A; Seth R; Forscher C; D'Amato G; Chawla SP; McCarthy S; Wang G; Parekh T; Knoblauch R; Hensley ML; Maki RG; Demetri GD
Cancer; 2019 Aug; 125(15):2610-2620. PubMed ID: 31173362
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma.
Mentzel T; Fletcher CD
Histopathology; 1997 May; 30(5):457-63. PubMed ID: 9181367
[TBL] [Abstract][Full Text] [Related]
14. Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas.
Jones RL; Le Cesne A; Ibrahim T; Garcia Del Muro X; Menge F
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1241-1248. PubMed ID: 30220224
[TBL] [Abstract][Full Text] [Related]
15. Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.
Strippoli S; Lorusso V; Albano A; Guida M
BMC Complement Altern Med; 2013 Jul; 13():199. PubMed ID: 23899130
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.
Saponara M; Stacchiotti S; Gronchi A
Expert Rev Anticancer Ther; 2016 May; 16(5):473-84. PubMed ID: 27043847
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Demetri GD; von Mehren M; Jones RL; Hensley ML; Schuetze SM; Staddon A; Milhem M; Elias A; Ganjoo K; Tawbi H; Van Tine BA; Spira A; Dean A; Khokhar NZ; Park YC; Knoblauch RE; Parekh TV; Maki RG; Patel SR
J Clin Oncol; 2016 Mar; 34(8):786-93. PubMed ID: 26371143
[TBL] [Abstract][Full Text] [Related]
18. Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective.
Shamai S; Merimsky O
Isr Med Assoc J; 2018 Oct; 20(10):599-603. PubMed ID: 30324774
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Jones RL; Demetri GD; Schuetze SM; Milhem M; Elias A; Van Tine BA; Hamm J; McCarthy S; Wang G; Parekh T; Knoblauch R; Hensley ML; Maki RG; Patel S; von Mehren M
Ann Oncol; 2018 Sep; 29(9):1995-2002. PubMed ID: 30084934
[TBL] [Abstract][Full Text] [Related]
20. Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report.
Nteli VA; Knauf W; Janton-Klein A; El-Safadi S
Case Rep Oncol; 2018; 11(1):81-89. PubMed ID: 29515415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
